Biotech Co. Merits Extra $1.2M Research Credit, 4th Circ. Told
A biotechnology company was wrongly stripped of tax credits for increasing its scientific research, it told the Fourth Circuit on Monday, saying it correctly excluded $26.6 million in clinical testing expenses...To view the full article, register now.
Already a subscriber? Click here to view full article